PMDA — authorised 23 January 2020
- Marketing authorisation holder: Fuji Yakuhin
- Status: approved
PMDA authorised Urece on 23 January 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 January 2020.
Fuji Yakuhin holds the Japanese marketing authorisation.